Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_assertion type Assertion NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_head.
- NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_assertion description "[The estimated population-attributable risk of recurrence for FVL was 9.0% (95% CI, 4.5%-13.2%) and for prothrombin G20210A was 6.7% (95% CI, 3.4%-9.9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_provenance.
- NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_assertion evidence source_evidence_literature NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_provenance.
- NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_assertion SIO_000772 16606808 NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_provenance.
- NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_assertion wasDerivedFrom befree-20150227 NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_provenance.
- NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_assertion wasGeneratedBy ECO_0000203 NP389876.RAcxhvsDj8exRDxM7Jis36PoK5HBtzzsqDHzg5J8uxkfY130_provenance.